Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Nereus
    Junior Member
    • Sep 2020
    • 2

    AMPure XP clumps during Cas9 library prep

    Hi everyone,
    I'm using the ONT CRISPR-Cas9 targeted enrichment protocol (https://www.nature.com/articles/s41587-020-0407-5) to sequence a 18kb locus in DNA which I extracted from human brain using the Circulomics Nanobind kit (which is recommended for this application). The protocol has worked well on a few occasions (around 120x coverage, which I understand is all right for this application), but on other occasions the coverage was quite poor (e.g. 6x), despite the DNA being very high quality (>60kb on Genomic Tapestation).

    I suspect that the low coverage stems from a problem during the library prep:

    After Cas9-directed cleavage of DNA and ligation of ONT adapters, the library is purified with 0.3x AMPure XP beads. I have observed on several occasions that the beads form insoluble clumps the moment that they are added to the tube, and I suspect that much of the library is lost within the clump. I have tried prolonged incubation and gentle agitation, but I couldn't dissolve the clump, neither in the ONT Long Frament Buffer, nor in the elution buffer.

    Has someone got any tips on how to avoid this issue?
  • gringer
    David Eccles (gringer)
    • May 2011
    • 845

    #2
    Try needle-shearing your DNA prior to doing the CRISPR-Cas9 digest, e.g. 20 passes with a 26G or 29G needle (see here for more information). This has been working well for us to make the samples easier to handle and quantify.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Working...